Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wellnex LifeASX:WNX +9.09% EV-to-EBITDA is -2.02 as of Jul. 16, 2026. The stock has 2 warning signs investors should review. Among 1,641 Consumer Packaged Goods companies, Wellnex Life ranks worse than 60938.39% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Wellnex Life's enterprise value is A$13.44 Mil.
Wellnex Life's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-6.65 Mil. Therefore, Wellnex Life's EV-to-EBITDA for today is -2.02.
The historical rank and industry rank for Wellnex Life's EV-to-EBITDA or its related term are showing as below:
ASX:WNX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -48.23 Med: -2.19 Max: -0.56
Current: -2.01
During the past 9 years, the highest EV-to-EBITDA of Wellnex Life was -0.56. The lowest was -48.23. And the median was -2.19.
ASX:WNX's EV-to-EBITDA is ranked worse than 100% of 1641
companies
in the Consumer Packaged Goods industry
Industry Median: 9.04
vs ASX:WNX: -2.01
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Wellnex Life (ASX:WNX) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Wellnex Life's PE Ratio (TTM) for today is calculated as:
Wellnex Life's share price for today is A$0.06.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wellnex Life's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.304.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Wellnex Life's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Wellnex Life's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellnex Life EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Wellnex Life's EV-to-EBITDA falls into.
Wellnex Life's current Enterprise Value is A$13.44 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wellnex Life's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-6.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellnex Life (ASX:WNX) has a EV-to-EBITDA of -2.02 as of Jul. 16, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wellnex Life. According to the industry distribution chart, Wellnex Life ranks #999999 out of 1641 companies in the Consumer Packaged Goods industry.
Is Wellnex Life's EV-to-EBITDA too high?
Wellnex Life's current EV-to-EBITDA is -2.02. Based on the distribution chart, Wellnex Life ranks #999999 out of 1641 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Wellnex Life's EV-to-EBITDA compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #999999 out of 1641 companies for EV-to-EBITDA. This places Wellnex Life in the lower half of its industry. The industry median EV-to-EBITDA is 9.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.04, based on 1,641 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wellnex Life. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellnex Life's current EV-to-EBITDA is -2.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.34, compared to a current price of A$0.06 — trading 82.4% below its estimated fair value. The current EV-to-EBITDA is -2.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current EV-to-EBITDA is -2.02 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WNX has been successfully added to your 
